| Literature DB >> 28514662 |
Aline Van Acker1, Konrad Gronke2, Aindrila Biswas3, Liesbet Martens4, Yvan Saeys4, Jessica Filtjens5, Sylvie Taveirne5, Els Van Ammel5, Tessa Kerre5, Patrick Matthys6, Tom Taghon5, Bart Vandekerckhove5, Jean Plum5, Ildiko Rita Dunay3, Andreas Diefenbach7, Georges Leclercq8.
Abstract
The Ly49E receptor is preferentially expressed on murine innate-like lymphocytes, such as epidermal Vγ3 T cells, intestinal intraepithelial CD8αα+ T lymphocytes, and CD49a+ liver natural killer (NK) cells. As the latter have recently been shown to be distinct from conventional NK cells and have innate lymphoid cell type 1 (ILC1) properties, we investigated Ly49E expression on intestinal ILC populations. Here, we show that Ly49E expression is very low on known ILC populations, but it can be used to define a previously unrecognized intraepithelial innate lymphoid population. This Ly49E-positive population is negative for NKp46 and CD8αα, expresses CD49a and CD103, and requires T-bet expression and IL-15 signaling for differentiation and/or survival. Transcriptome analysis reveals a group 1 ILC gene profile, different from NK cells, iCD8α cells, and intraepithelial ILC1. Importantly, NKp46-CD8αα-Ly49E+ cells produce interferon (IFN)-γ, suggesting that this previously unrecognized population may contribute to Th1-mediated immunity.Entities:
Keywords: IFN-γ; ILC1; Ly49E; NKp46-negative; intestinal; intraepithelial
Mesh:
Substances:
Year: 2017 PMID: 28514662 DOI: 10.1016/j.celrep.2017.04.068
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423